MALVERN, PA — TELA Bio Inc. (NASDAQ: TELA) announced that its board’s Compensation Committee approved inducement grants of restricted stock units covering 8,550 shares of common stock to three newly hired employees, effective February 18, 2026, as part of their employment compensation.
The company said the awards were granted under Nasdaq Rule 5635(c)(4), which permits equity awards to new hires as an inducement to accept employment.
The restricted stock units will vest in equal annual installments over four years, subject to each employee’s continued service through the applicable vesting dates.
TELA Bio is a commercial-stage medical technology company focused on soft-tissue reconstruction products designed to support tissue preservation and restoration. The company is publicly traded on Nasdaq under the ticker symbol TELA.
Support the local news that supports Chester County. MyChesCo delivers reliable, fact-based reporting and essential community resources—free for everyone. If you value that, click here to become a patron today.